University of Malaya (UM) / Universiti Malaya

Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation (2016) Ghoussaini M, French JD, Michailidou K, Nord S, Beesley J, Canisus S, Hillman KM, et al. Journal article Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer (2016) Shi J, Zhang Y, Zheng W, Michailidou K, Ghoussaini M, Bolla MK, Wang Q, et al. Journal article Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer (2016) Hampras SS, Sucheston-Campbell LE, Cannioto R, Chang-Claude J, Modugno F, Doerk T, Hillemanns P, et al. Journal article Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression (2015) Darabi H, Mccue K, Beesley J, Michailidou K, Nord S, Kar S, Humphreys K, et al. Journal article Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk (2015) Amankwah EK, Lin HY, Tyrer JP, Lawrenson K, Dennis J, Chornokur G, Aben KKH, et al. Journal article Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer (2015) Lawrenson K, Li Q, Kar S, Seo JH, Tyrer J, Spindler TJ, Lee J, et al. Journal article Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk (2015) Chornokur G, Lin HY, Tyrer JP, Lawrenson K, Dennis J, Amankwah EK, Qu X, et al. Journal article Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer (2015) Lawrenson K, Iversen ES, Tyrer J, Weber RP, Concannon P, Hazelett DJ, Li Q, et al. Journal article Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer risk (2015) Guo X, Long J, Zeng C, Michailidou K, Ghoussaini M, Bolla MK, Wang Q, et al. Journal article Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy (2015) Lei J, Rudolph A, Moysich KB, Rafiq S, Behrens S, Goode EL, Pharoah PP, et al. Journal article